Protective murine monoclonal antibodies to Cryptococcus neoformans

J. Mukherjee, Matthew D. Scharff, A. Casadevall

Research output: Contribution to journalArticle

206 Citations (Scopus)

Abstract

Several murine monoclonal antibodies (MAbs) specific for the capsular glucuronoxylomannan of Cryptococcus neoformans were studied for their capacity to confer protection when passively administered to lethally infected mice. The MAb group studied recognized at least three distinct epitopes and included immunoglobulin M (IgM), IgG3, IgG1, and IgA isotypes. The protection model used A/J and BALB/c mice infected intraperitoneally with 108 cryptococci. The MAbs were administered either immediately preceding or, in one experiment, 24 to 48 h prior to infection. Protective efficacy was assessed by the ability of passively administered MAbs to prolong the survival of lethally infected mice. Three IgM MAbs, each of which recognized a distinct epitope, were able to prolong survival of lethally infected mice to different extents. A set of IgM, IgG3, IgG1 and IgA MAbs which utilize the same immunoglobulin gene elements and were derived from the same B-cell clone exhibited significant class differences in protective efficacy with IgA, IgG1 > IgM > IgG3. The results confirm that protective MAbs against C. neoformans capsular polysaccharide exist and strongly suggest that both epitope specificity and isotype are important determinants of protective efficacy.

Original languageEnglish (US)
Pages (from-to)4534-4541
Number of pages8
JournalInfection and Immunity
Volume60
Issue number11
StatePublished - 1992

Fingerprint

Cryptococcus neoformans
Immunoglobulin G
Monoclonal Antibodies
Immunoglobulin M
Immunoglobulin A
Epitopes
Cryptococcus
Immunoglobulin Genes
Polysaccharides
B-Lymphocytes
Clone Cells
Infection

ASJC Scopus subject areas

  • Immunology

Cite this

Protective murine monoclonal antibodies to Cryptococcus neoformans. / Mukherjee, J.; Scharff, Matthew D.; Casadevall, A.

In: Infection and Immunity, Vol. 60, No. 11, 1992, p. 4534-4541.

Research output: Contribution to journalArticle

Mukherjee, J, Scharff, MD & Casadevall, A 1992, 'Protective murine monoclonal antibodies to Cryptococcus neoformans', Infection and Immunity, vol. 60, no. 11, pp. 4534-4541.
Mukherjee, J. ; Scharff, Matthew D. ; Casadevall, A. / Protective murine monoclonal antibodies to Cryptococcus neoformans. In: Infection and Immunity. 1992 ; Vol. 60, No. 11. pp. 4534-4541.
@article{49b7dbd938db49f8ae3df8a67669e55a,
title = "Protective murine monoclonal antibodies to Cryptococcus neoformans",
abstract = "Several murine monoclonal antibodies (MAbs) specific for the capsular glucuronoxylomannan of Cryptococcus neoformans were studied for their capacity to confer protection when passively administered to lethally infected mice. The MAb group studied recognized at least three distinct epitopes and included immunoglobulin M (IgM), IgG3, IgG1, and IgA isotypes. The protection model used A/J and BALB/c mice infected intraperitoneally with 108 cryptococci. The MAbs were administered either immediately preceding or, in one experiment, 24 to 48 h prior to infection. Protective efficacy was assessed by the ability of passively administered MAbs to prolong the survival of lethally infected mice. Three IgM MAbs, each of which recognized a distinct epitope, were able to prolong survival of lethally infected mice to different extents. A set of IgM, IgG3, IgG1 and IgA MAbs which utilize the same immunoglobulin gene elements and were derived from the same B-cell clone exhibited significant class differences in protective efficacy with IgA, IgG1 > IgM > IgG3. The results confirm that protective MAbs against C. neoformans capsular polysaccharide exist and strongly suggest that both epitope specificity and isotype are important determinants of protective efficacy.",
author = "J. Mukherjee and Scharff, {Matthew D.} and A. Casadevall",
year = "1992",
language = "English (US)",
volume = "60",
pages = "4534--4541",
journal = "Infection and Immunity",
issn = "0019-9567",
publisher = "American Society for Microbiology",
number = "11",

}

TY - JOUR

T1 - Protective murine monoclonal antibodies to Cryptococcus neoformans

AU - Mukherjee, J.

AU - Scharff, Matthew D.

AU - Casadevall, A.

PY - 1992

Y1 - 1992

N2 - Several murine monoclonal antibodies (MAbs) specific for the capsular glucuronoxylomannan of Cryptococcus neoformans were studied for their capacity to confer protection when passively administered to lethally infected mice. The MAb group studied recognized at least three distinct epitopes and included immunoglobulin M (IgM), IgG3, IgG1, and IgA isotypes. The protection model used A/J and BALB/c mice infected intraperitoneally with 108 cryptococci. The MAbs were administered either immediately preceding or, in one experiment, 24 to 48 h prior to infection. Protective efficacy was assessed by the ability of passively administered MAbs to prolong the survival of lethally infected mice. Three IgM MAbs, each of which recognized a distinct epitope, were able to prolong survival of lethally infected mice to different extents. A set of IgM, IgG3, IgG1 and IgA MAbs which utilize the same immunoglobulin gene elements and were derived from the same B-cell clone exhibited significant class differences in protective efficacy with IgA, IgG1 > IgM > IgG3. The results confirm that protective MAbs against C. neoformans capsular polysaccharide exist and strongly suggest that both epitope specificity and isotype are important determinants of protective efficacy.

AB - Several murine monoclonal antibodies (MAbs) specific for the capsular glucuronoxylomannan of Cryptococcus neoformans were studied for their capacity to confer protection when passively administered to lethally infected mice. The MAb group studied recognized at least three distinct epitopes and included immunoglobulin M (IgM), IgG3, IgG1, and IgA isotypes. The protection model used A/J and BALB/c mice infected intraperitoneally with 108 cryptococci. The MAbs were administered either immediately preceding or, in one experiment, 24 to 48 h prior to infection. Protective efficacy was assessed by the ability of passively administered MAbs to prolong the survival of lethally infected mice. Three IgM MAbs, each of which recognized a distinct epitope, were able to prolong survival of lethally infected mice to different extents. A set of IgM, IgG3, IgG1 and IgA MAbs which utilize the same immunoglobulin gene elements and were derived from the same B-cell clone exhibited significant class differences in protective efficacy with IgA, IgG1 > IgM > IgG3. The results confirm that protective MAbs against C. neoformans capsular polysaccharide exist and strongly suggest that both epitope specificity and isotype are important determinants of protective efficacy.

UR - http://www.scopus.com/inward/record.url?scp=0026495128&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026495128&partnerID=8YFLogxK

M3 - Article

VL - 60

SP - 4534

EP - 4541

JO - Infection and Immunity

JF - Infection and Immunity

SN - 0019-9567

IS - 11

ER -